Drug Shortage Report for SYNTHROID
| Report ID | 131538 |
| Drug Identification Number | 02172127 |
| Brand name | SYNTHROID |
| Common or Proper name | LEOTHYROXINE |
| Company Name | BGP PHARMA ULC |
| Market Status | MARKETED |
| Active Ingredient(s) | LEVOTHYROXINE SODIUM |
| Strength(s) | 150MCG |
| Dosage form(s) | TABLET |
| Route of administration | ORAL ORAL |
| Packaging size | 90BT, 1000BT |
| ATC code | H03AA |
| ATC description | THYROID PREPARATIONS |
| Reason for shortage | Disruption of the manufacture of the drug. |
| Anticipated start date | |
| Actual start date | 2021-01-04 |
| Estimated end date | 2021-01-19 |
| Actual end date | 2021-01-20 |
| Shortage status | Resolved |
| Updated date | 2021-01-21 |
| Company comments | |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 85 ADVANCE ROAD ETOBICOKE, ONTARIO CANADA M8Z 2S6 |
| Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v5 | 2021-01-21 | English | Compare |
| v4 | 2021-01-20 | French | Compare |
| v3 | 2021-01-20 | English | Compare |
| v2 | 2021-01-14 | French | Compare |
| v1 | 2021-01-14 | English | Compare |
Showing 1 to 5 of 5